Evaluate approaches to manage immune-related adverse effects associated with immune checkpoint inhibitors in patients with genitourinary cancer, including renal cell and bladder cancer.

Evaluating the Nonspecific Symptoms of ILD: Guideline-based Strategies for Earlier Detection of IPF

Apply updated efficacy and safety data, recent guidelines, and individual patient characteristics, such as comorbidities, when making treatment decisions for patients with idiopathic pulmonary fibrosis.

Engage in a multidisciplinary roundtable discussion to discuss how to best optimize and individualize hypercholesterolemia management with newer therapies.

Describe the latest clinical guidelines and recommendations for the use of proprotein convertase subtilisin kexin type 9 inhibitors (PCKS9i)

Complete this mystery patient case study by applying your knowledge to diagnose and treat Colin before it’s too late.

This webcast will examine the implications of B-cell NHLs as a disease, including accurate diagnosis, risk stratification and molecular biomarkers, to aid prognosis and treatment choice.

Advancements in novel therapies and technologies, lifestyle medicine, multidisciplinary approaches that are driving improvements in outcomes and quality, and cardiovascular (CVD)/metabolic disease prevention.

Assess optimal time to initiate treatment for FL in order to delay disease progression and maintain patient quality of life